Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

UK cancer death rates drop by 20 per cent over 20 years

UK cancer death rates drop by 20 per cent over 20 years

ASH 2013: Study identifies reasons for CML non-adherence

ASH 2013: Study identifies reasons for CML non-adherence

SABCS 2013: New drug combo delayed disease progression for subgroup of women with metastatic breast cancer

SABCS 2013: New drug combo delayed disease progression for subgroup of women with metastatic breast cancer

ASH 2013: Early suggestion of cure in Hodgkin lymphoma patients treated with brentuximab vedotin

ASH 2013: Early suggestion of cure in Hodgkin lymphoma patients treated with brentuximab vedotin

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

ASH 2013: Siltuximab shows efficacy for multicentric castleman’s disease

ASH 2013: Siltuximab shows efficacy for multicentric castleman’s disease

£100m investment in research centres across the UK

£100m investment in research centres across the UK

ASH 2013: IPI-145 may lend itself well to long-term therapy of patients with CLL

ASH 2013: IPI-145 may lend itself well to long-term therapy of patients with CLL

ASH 2013: Final stage II results of the CLL11 trial

ASH 2013: Final stage II results of the CLL11 trial

ASH 2013: Bcl-2 inhibitor ABT-199 monotherapy shows anti-tumour activity in high-risk chronic lymphocytic leukaemia and small lymphocytic lymphoma

ASH 2013: Bcl-2 inhibitor ABT-199 monotherapy shows anti-tumour activity in high-risk chronic lymphocytic...

More from ecancer